Position in KMDA
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$67,388
-$17,980 QoQ
Shares Held
9,181
-10.3% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 51 holders
Holding Since
Sep 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KMDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026China Universal Asset Management Co., Ltd. holds $16,477,419 across 28 Drug Manufacturers - Specialty & Generic names. KMDA ranks #25 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
6,755 | $3,660,061 | |
| 2 | VTRS |
Viatris Inc
|
185,339 | $2,943,183 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
16,003 | $2,697,145 | |
| 4 | ALKS |
Alkermes plc.
|
26,527 | $1,389,882 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
50,773 | $878,880 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
19,404 | $796,146 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,369 | $471,247 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
9,237 | $429,612 |
All Filings in KMDA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,388 | 9,181 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $85,368 | 10,236 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $66,356 | 9,399 | Shares | Sole | 2026-01-29 | |
| 2022-09-30 | $1,889 | 419 | Shares | Sole | 2022-10-21 | |
| No filing history on record for this holder in this stock. | ||||||